6:30–7:45 am
IWMB700 Breakfast Workshop – Regulatory Toolkit: 2012
Presented by McKesson
IWMB701 Breakfast Workshop – The Pathwork Tissue of Origin Test and Immunohistochemistry: Determining the Primary Site of Metastatic Cancer
Presented by Pathwork
IWMB702 Breakfast Workshop – Agilent & Dako: Uniting Anatomical and Molecular Pathology
Presented by Agilent Technologies
The CAP does not endorse the content of the industry workshops, individual presenters, or sponsoring companies.
8:00–9:00 am
AP107 Treatment Implication of ER-Positive and HER2-Positive Breast Cancer—The Critical Role of Pathologists NEW
David G. Hicks, MD, FCAP
Ping Tang, MD, PhD, FCAP
CP105 Thyroid Testing: Key Clinical and Laboratory Controversies
Anthony A. Killeen, MD, PhD, FCAP
8:00–11:30 am
AP108 Biopsy Diagnosis of Colitis: Challenges and Solutions
Ian S. Brown, MD, FRCPA
Gregory Y. Lauwers, MD, FCAP
AP109 Recognizing the High-Risk “Benign” Endometrial Biopsy
George L. Mutter, MD, FCAP
Marisa R. Nucci, MD, FCAP
AP110 Diagnostic Aspects of Pulmonary Adenocarcinoma
Keith M. Kerr, MBChB, IFCAP
AP111 Myeloid Neoplasms: Morphology to Molecular Genetics NEW
Daniel A. Arber, MD
Tracy I. George, MD, FCAP
PM103 Establishing a Laboratory Test Utilization Management Program: Organizational Structure, Informatics, and the Central Role of the Pathologist NEW
Anand S. Dighe, MD, PhD
Kent B. Lewandrowski, MD, FCAP
ST103 What’s in It for Me? Using Technology to Become a Diagnostic Hero
Kenneth J. Bloom, MD, FCAP
Jonhan Ho, MD, FCAP
David C. Wilbur, MD, FCAP
ST104 High-Impact Communications Boot Camp
Kim A. Collins, MD, FCAP
Rebecca L. Johnson, MD, FCAP
Sandra B. Grear
9:30–11:30 am
AP112 Practical Challenges in Bone Marrow Evaluation
David R. Czuchlewski, MD
Kaaren K. Reichard, MD, FCAP
Carla S. Wilson, MD, PhD, FCAP
AP113 Molecular Testing Guidelines for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors NEW
Marc Ladanyi, MD, FCAP
Neal I. Lindeman, MD, FCAP
CP106 Laboratory Methods for Detecting Fetomaternal Hemorrhage and Calculating the Dose of Rh Immune Globulin
Jerome L. Gottschall, MD, FCAP
S. Gerald Sandler, MD, FCAP
VM105 Practical Tips for Diagnosing Difficult Melanocytic Lesions: What We Know, What We Don’t Know, and What to Do Next
Maxwell A. Fung, MD, FCAP
Round Table Discussions—Lunch Included
Noon–1:00 pm
Join the experts for lunch! Exchange information and share solutions in a relaxed setting with your peers.
You will learn to:
• Apply solutions to common problems through interactive
sessions with colleagues
RT103 The New Transfusion Trigger, Hemoglobin of 7! NEW
Leonard I. Boral, MD, MBA, FCAP
RT104 Case Studies in Practice Management
Krista L. Crews, CPA
Michael L. Talbert, MD, FCAP
RT105 Implementing an EMR: Perspectives on the Laboratory Director’s Role
John R. Harbour, MD, FCAP
RT106 Getting Financial and Intellectual Value From Molecular Send-out Testing
Jeffrey A. Kant, MD, PhD, FCAP
RT114 Blood Management: Proper Blood Utilization NEW
Lowell L. Tilzer, MD, PhD, FCAP
2:00–4:00 pm
AP114 Nonneoplastic Diseases of the Genitourinary Tract: Benign Lesions Matter Too
Anthony Chang, MD, FCAP
Gladell P. Paner, MD
AP115 Molecular Workup of Lung Fine-Needle Aspiration (FNA) Specimens by Tumor Type
Maureen F. Zakowski, MD, FCAP
ST105 CAP Foundation Keitges Program on Medical Ethics: Genetic Testing in Late Onset Autosomal Dominant Disorders
Kimberly A. Quaid, PhD
Gail H. Vance, MD, FCAP
VM106 After-Hours Dialogue With the Neurosurgeon NEW
Cynthia T. Welsh, MD, FCAP
VM107 Uncommon Tumors and Their Place in Lung Cancer Classification NEW
Alain C. Borczuk, MD, FCAP
Lucian R. Chirieac, MD, FCAP
2:00–5:30 pm
AP116 Cytologic/FNA Evaluation of Lymphoid Proliferations: Integration of Clinical, Morphologic, Flow Cytometric, FISH, and Molecular Testing in Diagnosis and Classification NEW
Anne M. Deucher, MD, PhD, FCAP
Joan E. Etzell, MD, FCAP
Stephanie J. McAlhany, MD, PhD, FCAP
AP117 Problems in the Evaluation of Breast Needle Core Biopsies
Sandra J. Shin, MD, FCAP
AP118 Infectious Disease of the Lower Respiratory Tract NEW
Geoffrey A. Land, PhD, HCLD
Randall J. Olsen, MD, PhD
AP119 The Role of Immunohistochemistry in the Evaluation of Skin Tumors NEW
Jose A. Plaza, MD
Victor G. Prieto, MD, PhD, FCAP
CP107 Pathologists Are Coagulation Consultants: New Challenges and Updates NEW
Charles S. Eby, MD, FCAP
Russell A. Higgins, MD, FCAP
Vandita P. Johari, MD, FCAP
ST113 Multidisciplinary Approach to Endocrine Pathology
James D. Faix, MD, FCAP
Jason D. Merker, MD, PhD, FCAP
Peter M. Sadow, MD, PhD, FCAP
4:30–5:30 pm
PM104 Professional Practice Evaluation and the Joint Commission: What You Need to Know to Comply
Jennifer L. Hunt, MD, MEd, FCAP
Donald S. Karcher, MD, FCAP
6:15–8:15 pm
MP500 CAP Mentor Program Orientation and Kick-off Dinner
6:30–8:30 pm
VM108 Practical Tips for Diagnosing Difficult Melanocytic Lesions: What We Know, What We Don’t Know, and What to Do Next
Maxwell A. Fung, MD, FCAP
VM109 After Hours Dialogue With the Neurosurgeon NEW
Cynthia T. Welsh, MD, FCAP
6:15 pm
IWMD900 Dinner Workshop – The Essential Role of a Pathologist in the Era of Personalized Medicine
Presented by Integrated Oncology
IWMD910 Dinner Workshop – Enabling more Confident Decisions for Cancer Treatment
Presented by Clarient, a GE Healthcare Company
IWMD920 Dinner Workshop – Workup of the Abnormal CBC in the Molecular Era: Algorithms and Recommendations for Additional Testing in Diagnosing Benign and Neoplastic Hematologic Conditions in Blood
Presented by Quest Diagnostics
The CAP does not endorse the content of the industry workshops, individual presenters, or sponsoring companies.